Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity

Two sides of the same coin

P. Alberti, E. Rossi, David Cornblath, I. S J Merkies, T. J. Postma, B. Frigeni, J. Bruna, R. Velasco, A. A. Argyriou, H. P. Kalofonos, D. Psimaras, D. Ricard, A. Pace, E. Galiè, C. Briani, C. Dalla Torre, C. G. Faber, R. I. Lalisang, W. Boogerd, D. Brandsma & 8 others S. Koeppen, J. Hense, D. Storey, S. Kerrigan, A. Schenone, S. Fabbri, M. G. Valsecchi, G. Cavaletti

Research output: Contribution to journalArticle

Abstract

Background: The different perception and assessment of chemotherapy-induced peripheral neurotoxicity (CIPN) between healthcare providers and patients has not yet been fully addressed, although these two approaches might eventually lead to inconsistent, possibly conflicting interpretation, especially regarding sensory impairment. Patients and methods: A cohort of 281 subjects with stable CIPN was evaluated with the National Cancer Institute- Common Toxicity Criteria (NCI-CTC v. 2.0) sensory scale, the clinical Total Neuropathy Score (TNSc

Original languageEnglish (US)
Article numbermdt409
Pages (from-to)257-264
Number of pages8
JournalAnnals of Oncology
Volume25
Issue number1
DOIs
StatePublished - 2014

Fingerprint

Physicians
Drug Therapy
National Cancer Institute (U.S.)
Health Personnel
Patient Reported Outcome Measures

ASJC Scopus subject areas

  • Oncology
  • Hematology

Cite this

Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity : Two sides of the same coin. / Alberti, P.; Rossi, E.; Cornblath, David; Merkies, I. S J; Postma, T. J.; Frigeni, B.; Bruna, J.; Velasco, R.; Argyriou, A. A.; Kalofonos, H. P.; Psimaras, D.; Ricard, D.; Pace, A.; Galiè, E.; Briani, C.; Dalla Torre, C.; Faber, C. G.; Lalisang, R. I.; Boogerd, W.; Brandsma, D.; Koeppen, S.; Hense, J.; Storey, D.; Kerrigan, S.; Schenone, A.; Fabbri, S.; Valsecchi, M. G.; Cavaletti, G.

In: Annals of Oncology, Vol. 25, No. 1, mdt409, 2014, p. 257-264.

Research output: Contribution to journalArticle

Alberti, P, Rossi, E, Cornblath, D, Merkies, ISJ, Postma, TJ, Frigeni, B, Bruna, J, Velasco, R, Argyriou, AA, Kalofonos, HP, Psimaras, D, Ricard, D, Pace, A, Galiè, E, Briani, C, Dalla Torre, C, Faber, CG, Lalisang, RI, Boogerd, W, Brandsma, D, Koeppen, S, Hense, J, Storey, D, Kerrigan, S, Schenone, A, Fabbri, S, Valsecchi, MG & Cavaletti, G 2014, 'Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: Two sides of the same coin', Annals of Oncology, vol. 25, no. 1, mdt409, pp. 257-264. https://doi.org/10.1093/annonc/mdt409
Alberti, P. ; Rossi, E. ; Cornblath, David ; Merkies, I. S J ; Postma, T. J. ; Frigeni, B. ; Bruna, J. ; Velasco, R. ; Argyriou, A. A. ; Kalofonos, H. P. ; Psimaras, D. ; Ricard, D. ; Pace, A. ; Galiè, E. ; Briani, C. ; Dalla Torre, C. ; Faber, C. G. ; Lalisang, R. I. ; Boogerd, W. ; Brandsma, D. ; Koeppen, S. ; Hense, J. ; Storey, D. ; Kerrigan, S. ; Schenone, A. ; Fabbri, S. ; Valsecchi, M. G. ; Cavaletti, G. / Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity : Two sides of the same coin. In: Annals of Oncology. 2014 ; Vol. 25, No. 1. pp. 257-264.
@article{63a26305425748099e5988d273dac435,
title = "Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: Two sides of the same coin",
abstract = "Background: The different perception and assessment of chemotherapy-induced peripheral neurotoxicity (CIPN) between healthcare providers and patients has not yet been fully addressed, although these two approaches might eventually lead to inconsistent, possibly conflicting interpretation, especially regarding sensory impairment. Patients and methods: A cohort of 281 subjects with stable CIPN was evaluated with the National Cancer Institute- Common Toxicity Criteria (NCI-CTC v. 2.0) sensory scale, the clinical Total Neuropathy Score (TNSc",
author = "P. Alberti and E. Rossi and David Cornblath and Merkies, {I. S J} and Postma, {T. J.} and B. Frigeni and J. Bruna and R. Velasco and Argyriou, {A. A.} and Kalofonos, {H. P.} and D. Psimaras and D. Ricard and A. Pace and E. Gali{\`e} and C. Briani and {Dalla Torre}, C. and Faber, {C. G.} and Lalisang, {R. I.} and W. Boogerd and D. Brandsma and S. Koeppen and J. Hense and D. Storey and S. Kerrigan and A. Schenone and S. Fabbri and Valsecchi, {M. G.} and G. Cavaletti",
year = "2014",
doi = "10.1093/annonc/mdt409",
language = "English (US)",
volume = "25",
pages = "257--264",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity

T2 - Two sides of the same coin

AU - Alberti, P.

AU - Rossi, E.

AU - Cornblath, David

AU - Merkies, I. S J

AU - Postma, T. J.

AU - Frigeni, B.

AU - Bruna, J.

AU - Velasco, R.

AU - Argyriou, A. A.

AU - Kalofonos, H. P.

AU - Psimaras, D.

AU - Ricard, D.

AU - Pace, A.

AU - Galiè, E.

AU - Briani, C.

AU - Dalla Torre, C.

AU - Faber, C. G.

AU - Lalisang, R. I.

AU - Boogerd, W.

AU - Brandsma, D.

AU - Koeppen, S.

AU - Hense, J.

AU - Storey, D.

AU - Kerrigan, S.

AU - Schenone, A.

AU - Fabbri, S.

AU - Valsecchi, M. G.

AU - Cavaletti, G.

PY - 2014

Y1 - 2014

N2 - Background: The different perception and assessment of chemotherapy-induced peripheral neurotoxicity (CIPN) between healthcare providers and patients has not yet been fully addressed, although these two approaches might eventually lead to inconsistent, possibly conflicting interpretation, especially regarding sensory impairment. Patients and methods: A cohort of 281 subjects with stable CIPN was evaluated with the National Cancer Institute- Common Toxicity Criteria (NCI-CTC v. 2.0) sensory scale, the clinical Total Neuropathy Score (TNSc

AB - Background: The different perception and assessment of chemotherapy-induced peripheral neurotoxicity (CIPN) between healthcare providers and patients has not yet been fully addressed, although these two approaches might eventually lead to inconsistent, possibly conflicting interpretation, especially regarding sensory impairment. Patients and methods: A cohort of 281 subjects with stable CIPN was evaluated with the National Cancer Institute- Common Toxicity Criteria (NCI-CTC v. 2.0) sensory scale, the clinical Total Neuropathy Score (TNSc

UR - http://www.scopus.com/inward/record.url?scp=84894342495&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894342495&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdt409

DO - 10.1093/annonc/mdt409

M3 - Article

VL - 25

SP - 257

EP - 264

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 1

M1 - mdt409

ER -